Endovascular Treatment of Acute Stroke due to the Floating Carotid Thrombus with Intra-Arterial Tissue Plasminogen Activator and Stenting by Duman, Enes
 Cukurova Medical Journal 
 
 
 
Endovascular Treatment of Acute Stroke due to the 
Floating Carotid Thrombus with Intra-Arterial Tissue 
Plasminogen Activator and Stenting 
Hareketli Karotis Trombüsüne Bağlı Akut Strokun Stentleme ve İntra-arteryel 
Doku Plazminojen Aktivatörü ile Endovasküler Tedavisi 
Enes Duman 
Başkent University, Konya Research Center, Department of Interventional Radiology, KONYA 
Cukurova Medical Journal 2015;40 (Ek Sayı 1):142-146. 
 
ABSTRACT 
54-year-old male patient was admitted to emergency service with bilateral loss of sight, consciousness and a Glasgow 
Coma Scale score of 15. His neurologic examination revealed no lateralized deficit but left homonymous hemianopia. 
Brain CT and diffusion MRI showed acute infarction in the right parietal and occipital lobes. There was a wide penumbra 
region on brain perfusion CT. The selective angiography showed preocclusive stenosis at the origin of right internal 
carotid artery (ICA) and massive floating thrombus (FT) in the cervical ICA segment.We report successful endovascular 
treatment of FT in the ICA using intra-arterial tissue plasminogen activator and stenting.  
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ÖZET 
54 yaşında Glasgow koma skala skoru 15 olan erkek hasta acil servise bilateral görme kaybı, bilinç kaybı şikayeti ile 
başvurdu. Nörolojik muayenesinde lateralizasyon bulgusu izlenmeyen hastanın sol homonymous hemianopia’ sı 
mevcuttu. Beyin tomografisi ve beyin difüzyon MRG’ sinde sağ parietal ve oksipital lobda akut enfarkt saptandı. 
Perfüzyon BT tetkikinde geniş penumbra (kurtarılabilir alan- mismatch) alanı izlendi. Selektif karotit anjiyografi tetkikinde 
sağ internal karotit arter orjininde preokluziv darlık ve masif floating thrombus izlendi. Bu vakada intraarteriyel tPA ve 
stent kullanarak floating trombüsün başarılı endovasküler tedavisini paylaştık. 
Anahtar kelimeler: Floating trombüs, tPA, endovasküler stent yerleştirilmesi, karotit darlığı 
INTRODUCTION 
 Although the exact etiology of floating 
thrombus (FT) in the carotid artery is unknown, 
most cases are due to embolic thrombus or plaque 
rupture. FFT affects men more than women, with a 
ratio of nearly 2:1 at a younger age than most 
patients with carotid disease1. FT is a particularly 
difficult problem for the physician because most 
patients present with acute neurologic symptoms,  
 
 
and it is unclear whether surgical or medical 
treatment is the best option1. Most of the reports in 
the literature to date describe surgical intervention 
and medical treatment with similar success rates2-
4. Medical management for stabilizing neurologic 
deficits has less risk and less benefit than surgical 
intervention1.  
 Here, we report the successful endovascular 
treatment of acute FT in the carotid artery using 
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intra-arterial tissue plasminogen activator (tPA) 
and stenting. 
CASE  
 A 54-year-old male patient was admitted to 
emergency service with bilateral loss of sight, 
consciousness and a Glasgow Coma Scale score 
of 15. His neurologic examination revealed no 
lateralized deficit but left homonymous 
hemianopia. Brain CT and diffusion MRI showed 
acute infarction in the right parietal and occipital 
lobes. Because his symptoms began one hour 
earlier and a wide penumbra region was apparent 
on brain perfusion CT (Aqullion, Toshiba, Japan) , 
the patient was taken to the interventional 
radiology unit for endovascular revascularization. 
There was a miss-match between mean 
transmitting time and cerebral blood volume and it 
showed that patient had a wide penumbra region 
on brain perfusion CT. Perfusion CT levels are 
below. 
 
 CBV MTT 
1-Right 0.49      14.71 
2-Left 3.15 9.78 
% -74 +50 
 
 An informed consent was obtained from the 
patient and family members. The right carotid 
angiograph showed massive floating thrombus 
reaching from the origin of the ICA to the petrous 
segment of the ICA (Fig.1). There was reduced 
blood flow in the branches of the middle cerebral 
artery and no flow in the anterior cerebral artery 
(Fig.2). Because of high risk of distal embolism 
with massive FT, endarterectomy and 
endovascular mechanical thrombectomy were not 
performed. We decided to perform intra-arterial 
thrombolytic therapy. We placed 5F vertebral 
catheter into the right common carotid artery and 
the 4 mg tirofiban HCl (Aggrastat®, DSM 
Pharmaceuticals, North Carolina, ABD), 10 mg tPA  
 
(Actilyse®, Boehringer  Ingelheim  Pharma,  Riss, 
Germany) were given in fifteen minutes over the 
catheter with bolus-style. For sixteen hours, we 
continued to tPA infusion 1 mg per hour with 
controlling blood fibrinogen level every two hours. 
We stopped the tPA infusion because fibrinogen 
level dropped 425 mg/dL to 110 mg/dL at end of 
16 hour of tPA infusion. Then we continued to the 
anticoagulant treatment with 500 IU/hour heparin 
(Vasparin®, Mefar, Istanbul, Turkey) infusion for 8 
hours. The 24-hour control angiography showed 
that floating thrombus was resolved almost 
completely (Fig.3) and there was a critic stenosis 
at the origin of ICA, and quantity of residual 
thrombus in the distal segment of the stenosis and 
small thrombus particles were on the wall of the 
main carotid artery. So we decided to apply 
endovascular stent placement and angioplasty to 
the stenotic segment of ICA. 600 mg clopidogrel 
and 300 mg corasprin was given to the patient 
eight hour before the carotid artery stenting (CAS). 
In CAS procedure firstly, we reached to the distal 
branch of the external carotid artery with 0,035-
inch hydrophilic glide wire, and 5F vertebral 
catheter. Then, we exchanged available 5 Fr 
sheath on femoral artery with 6F longer sheath 
(Epsylar, Optimed, Ettlingen, Germany).We placed 
the filter device (Angioguard RX, Cordis 
Corporation, Miami, USA) to the petrous segment 
of ICA to avoid the distal embolism. Then 7mm x 
40 mm self-expandableclosed cell carotid stent 
(Carotid wall stent,Boston scientific,Galway, 
Ireland) were placed, and angioplasty with 5 mm 
balloon (Ultra-thin Diamond, Boston scientific, 
Galway, Ireland) was done. The control 
angiography, after CAS procedure, showed 
complete patency of ICA and distal flow (Fig. 4a, 
b). 75 mg clopidogrel and 300 mg corasprin were 
given daily after the procedure, and the patient 
was discharged on post-operative 7th day. The 
patient was followed-up with carotid artery Doppler 
US and brain CT at sixth month. He has no 
problem and followed-up uneventfully. 
 
 143 
Cilt/Volume 40 Yıl/Year 2015       Endovascular Stent Placement 
 
  
   
Figure 1. Lateral selective right carotid DSA image shows     Figure 2. AP cerebral angiography shows; partial blood  
preocclusive stenosis at the origin of ICA and massive      flow  in the branches of middle cerebral artery, and no  
floating thrombus (black arrows) in the cervical ICA            flow in the anterior cerebral artery 
segment. 
 
Figure 3. Lateral selective right carotid DSA image shows almost complete resolution of thrombus and pre-occlusive 
stenosis at the origin of the right ICA. 
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Figure 4a, b. Lateral right carotid (a), and AP cerebral (b) DSA images shows; 100% patency of right ICA after 
endovascular stent placement, and normal blood flow of both anterior and middle cerebral arteries and their branches.  
DISCUSSION 
 The suggested incidence of FT, because of 
the lack of a unified definition of FT, ranges 
between 0.4% and 0.7%. Additionally, FT may be 
misidentified intraoperatively as an atherosclerotic 
plaque instead of thrombus, thereby contributing to 
the underestimation of the incidence of this entity1. 
 Although the exact etiology of FT in the 
carotid artery is unknown, most cases are due to 
embolic thrombus or plaque rupture. FT has been 
reported as a rare cause of ischemic stroke. FTs 
usually show significant mobility with intact 
antegrade flow because portions are stuck to the 
injured arterial wall. Their instability can make them 
sources of recurrent artery-to-artery embolism. The 
most serious complication is detachment resulting 
in complete occlusion of the distal cerebral 
arteries. FT is a particularly difficult problem for the 
physician because most patients present with 
acute neurologic symptoms, and it is unclear 
whether surgical or medical treatment is superior. 
Medical management for stabilizing neurologic 
deficits carries less risk but also less potential 
benefit than surgical intervention1. Several 
treatment options for carotid stenosis with 
intraluminal thrombosis have been reported in the  
 
literature, such as endarterectomy, medical 
therapy and endovascular stent placement2-4.  
 The selective intra-arterial thrombolytic 
therapy with tPA has been used for acute 
intracranial occlusions, and lower extremity 
thromboembolism, but the use of tPA for the 
carotid thrombosis is not well established. 
Randomized studies of unfractionated heparin, 
low-molecular-weight heparins, or heparinoids for 
the treatment of acute ischemic strokes showed no 
proven benefit in reducing stroke-related mortality 
and morbidity, stroke recurrence, and prognosis5-8. 
The major concerns about the use of tPA are 
bleeding complication and dosage. Although it is 
not proven, the blood fibrinogen level monitoring 
may be prevent bleeding complication, and can be 
used as an independent indicator if it drops rapidly 
or below 150mg/dL9. We need clinical 
investigations that show relationships between 
blood fibrinogen level and bleeding complication 
when tPA used for treatment. 
 Emergent CEA is one of treatment options for 
these patients, but it has higher risk of distal 
embolism. The CEA may be the treatment of 
choice if the patient admitted 6-hour after the 
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symptom onset or absence of penumbra region on 
perfusion CT or MRI examinations.  
 In our case we performed intra-arterial 
thrombolytic therapy. Because there was a high 
risk of distal embolism with massive FT, 
endarterectomy and endovascular mechanical 
thrombectomy were not performed. After intra-
arterial thrombolytic treatment, endovascular 
treatment or CEA is suitable for patients. 
 In conclusion, we must evaluate each patient 
individually to determine the best treatment 
approach. For patients who have acute carotid FT 
and large penumbra region on brain perfusion 
examinations using of intra-arterial tPA is relatively 
safe and feasible and should be kept in mind. 
 Statement of Human and Animal Rights: All 
procedures involving human participants were in 
accordance with the ethical standards of the 
institutional and/or national research committee 
and with the 1964 Helsinki declaration and its later 
amendments or comparable ethical standards. 
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